{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:22:34Z","timestamp":1777922554746,"version":"3.51.4"},"reference-count":0,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2006,6]]},"abstract":"<jats:p>\n                    Although antimicrobial resistance rates among\n                    <jats:italic toggle=\"yes\">Streptococcus pneumoniae and Haemophilus influenzae<\/jats:italic>\n                    have\nincreased significantly in most countries in the last years, most studies from Brazil report relatively low resistance\nrates among these pathogens. In this study, we analyzed the susceptibility patterns of\n                    <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                    from Brazil during a 7-year period. A total of 829\n                    <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>\n                    and 718\n                    <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                    consecutively collected from 1998 to 2004, mainly from respiratory tract and bloodstream infections, were\nsusceptibility tested by broth microdilution methods against &gt;30 drugs and the results were analyzed by year.\nOverall, 77.8% of\n                    <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>\n                    strains were considered susceptible (MIC, \u22640.06\n                    <jats:italic toggle=\"yes\">\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    <\/jats:italic>\n                    g\/ml) to penicillin. Resistance\nto penicillin (MIC, \u22652\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml) and ceftriaxone (MIC, \u22654\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml) were detected in 7.5 and 0.5% of\nstrains, respectively. The fluoroquinolones, levofloxacin (MIC\n                    <jats:sub>90,<\/jats:sub>\n                    1\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml) and gatifloxacin (MIC\n                    <jats:sub>90,<\/jats:sub>\n                    0.5\n                    <jats:italic toggle=\"yes\">\n                      <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    <\/jats:italic>\n                    g\/ml),\nwere active against 99.8% of the isolates tested. Among the other non-\n                    <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                    -lactam drugs tested, the rank order\nof susceptibility rates was chloramphenicol (98.9%) &gt; clindamycin (96.4%) &gt; erythromycin (90.6%) &gt; tetracycline\n(69.8%) &gt; trimethoprim\/sulfamethoxazole (36.7%). Resistance to penicillin has increased markedly\namong\n                    <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>\n                    isolates over 7 years (from 2.9 to 11.0%). Additionally, resistance rates against erythromycin,\nclindamycin, and tetracycline decreased among pneumococcal strains during the same period.\n                    <jats:italic toggle=\"yes\">S.\npneumoniae<\/jats:italic>\n                    recovered from pediatric patients (\u22645 years) showed increased penicillin and trimethoprim\/sulfametroxazole\nresistance rates compared to older populations. The rate of ampicillin resistance among\n                    <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                    was 14.0%, which also corresponds with the\n                    <jats:italic toggle=\"yes\">\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                    <\/jats:italic>\n                    -lactamase production rate. All\n                    <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                    isolates\nwere susceptible to amoxicillin\/clavulanate (MIC\n                    <jats:sub>90,<\/jats:sub>\n                    1\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml), ceftriaxone (MIC\n                    <jats:sub>90,<\/jats:sub>\n                    \u2264 0.008\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml), cefepime\n(MIC\n                    <jats:sub>90,<\/jats:sub>\n                    0.12\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml), ciprofloxacin (MIC\n                    <jats:sub>90,<\/jats:sub>\n                    \u2264 0.12\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml), levofloxacin (MIC\n                    <jats:sub>90,<\/jats:sub>\n                    \u2264 0.5\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml), and gatifloxacin\n(MIC\n                    <jats:sub>90,<\/jats:sub>\n                    \u2264 0.03\n                    <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>\n                    g\/ml). Resistance to the antimicrobials tested remained very stable among\n                    <jats:italic toggle=\"yes\">H. influenzae<\/jats:italic>\n                    isolates\nduring the 7-year study period. The continued emerging antimicrobial resistances found in these\npathogens (mainly\n                    <jats:italic toggle=\"yes\">S. pneumoniae<\/jats:italic>\n                    ) highlight the need for alternative agents for the treatment of infections\ncaused by these species.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2006.12.91","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T15:42:43Z","timestamp":1153323763000},"page":"91-98","source":"Crossref","is-referenced-by-count":9,"title":["Changing Antimicrobial Susceptibility Patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998\u20132004)"],"prefix":"10.1177","volume":"12","author":[{"given":"Mariana","family":"Castanheira","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Gales","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio C.C.","family":"Pignatari","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio S.","family":"Sader","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."},{"name":"JMI Laboratories, North Liberty, Iowa."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2006,6]]},"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2006.12.91","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2006.12.91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:23:45Z","timestamp":1777667025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2006.12.91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1089\/mdr.2006.12.91"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2006.12.91","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}